Adolphus Hotel
Registration: www.regonline.com/DallasAMR
Antibody mediated rejection is a well-known and feared entity in all solid organ transplants – except the liver. Previous studies and literature regarding liver allografts have been inconsistent, and mounting evidence has shown the pathologic potential of DSA in liver and SLKT recipients. The goal of this ground-breaking conference is to bring about a meeting of the minds to define AMR in liver transplantation and forge a path for future research in this burgeoning area of research. The conference features an esteemed panel of experts in their fields, and is designed specifically for Transplant Surgeons, Transplant Pathologists, Transplant Hepatologists, Transplant Nephrologists, and HLA Laboratory PhDs. Please see this paper highlighting the importance of Donor Specific Antibodies (DSA) in simultaneous liver kidney transplant patients.